ArticleSignal transduction and targeted therapy2025

Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia.

Xiaoyan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.